X Bioscience PCL (BKK:XBIO-W7) LT-Debt-to-Total-Asset : 0.04 (As of Mar. 2025)

View and export this data going back to 2025. Start your Free Trial

What is X Bioscience PCL LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. X Bioscience PCL's long-term debt to total assests ratio for the quarter that ended in Mar. 2025 was 0.04.

X Bioscience PCL's long-term debt to total assets ratio declined from Mar. 2024 (0.14) to Mar. 2025 (0.04). It may suggest that X Bioscience PCL is progressively becoming less dependent on debt to grow their business.

X Bioscience PCL LT-Debt-to-Total-Asset Historical Data

The historical data trend for X Bioscience PCL's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

X Bioscience PCL LT-Debt-to-Total-Asset Chart

X Bioscience PCL Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.09

0.10

0.15

0.13

0.06

X Bioscience PCL Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.14	0.15	0.14	0.06	0.04

X Bioscience PCL LT-Debt-to-Total-Asset Calculation

X Bioscience PCL's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )	/	Total Assets (A: Dec. 2024 )
	=	77.496	/	1414.355
	=	0.05

X Bioscience PCL's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2025 is calculated as

LT Debt to Total Assets (Q: Mar. 2025 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2025 )	/	Total Assets (Q: Mar. 2025 )
	=	56.132	/	1360.72
	=	0.04

X Bioscience PCL (BKK:XBIO-W7) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

X Bioscience PCL LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of X Bioscience PCL's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

X Bioscience PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » X Bioscience PCL (BKK:XBIO-W7) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

XBIO:Thailand

Address

Phahon Yothin Road, No.304, Room No.1803-1806, 18th Floor, Vanit Place Aree Tower (Tower A, Sam Sen Nai, Bangkok, THA, 10400

Website

https://www.xbio.co.th

X Bioscience PCL is engaged in investment in food and beverages business and the group are engaged in selling food and beverages, and manufacturing and selling biological products. The group operates in two business segments: the food and beverage sales segment and the internal management services segment provided by the parent company. The group operates in a single geographic area, which is Thailand. The company's brand consists of Kagonaya, Bake, and Leboeuf.

X Bioscience PCL Headlines

No Headlines